Industry / Vietnam
Pharmaceutical Prices Rise Again
March 2011 | Industry Trend AnalysisBMI View: Vietnam's VND32,886bn (US$1.71bn) pharmaceutical market represents a moderate risk, high-return proposition for drugmakers. Demand for medicines is supported by a booming economy and political stability. Although per capita spending is low, market growth is high (five-year local currency compound annual growth rate (CAGR) = 14.6%). Key concerns include numerous unregulated pharmacies, irrational procurement methods and, most significantly, erratic prices.
To read the full article, please choose one of the following options:
Subcribers please log in




